Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …

Attention-deficit/hyperactivity disorder (ADHD) is defined by extreme levels of inattention–
disorganization and/or hyperactivity–impulsivity. In DSM-IV, the diagnostic criteria required …

Background Many children and adolescents with attention deficit/hyperactivity disorder
(ADHD) are treated with stimulant and non-stimulant medication. ADHD medication may be …

Background Prolongation of the corrected QT (QTc) interval is a key issue for patients who
receive psychotropic medications. Such patients may have baseline clinical risk factors for …

Context More than 1.5 million US adults use stimulants and other medications labeled for
treatment of attention-deficit/hyperactivity disorder (ADHD). These agents can increase heart …

Abstract Attention-Deficit/Hyperactivity Disorder is not a single pathophysiological entity and
appears to have a complex etiology. There are multiple genetic and environmental risk …

Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Narcolepsy and other syndromes associated with excessive daytime sleepiness can be
challenging to treat. New classifications now distinguish narcolepsy/hypocretin deficiency …

Introduction Methylphenidate remains a first-line medication for treating ADHD in children
and adults. However, its behavioral pharmacological similarities to methamphetamine and …

Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder
characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. The …